These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33468537)

  • 1. Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.
    Goeppert B; Stichel D; Toth R; Fritzsche S; Loeffler MA; Schlitter AM; Neumann O; Assenov Y; Vogel MN; Mehrabi A; Hoffmann K; Köhler B; Springfeld C; Weichenhan D; Plass C; Esposito I; Schirmacher P; von Deimling A; Roessler S
    Gut; 2022 Feb; 71(2):391-401. PubMed ID: 33468537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
    Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
    Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
    Bickenbach K; Galka E; Roggin KK
    Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomas.
    Tomita H; Tanaka K; Hirata A; Okada H; Imai H; Shirakami Y; Ohnishi K; Sugie S; Aoki H; Hatano Y; Noguchi K; Kanayama T; Niwa A; Suzui N; Miyazaki T; Tanaka T; Akiyama H; Shimizu M; Yoshida K; Hara A
    Cell Rep; 2021 Feb; 34(8):108772. PubMed ID: 33626352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraductal papillary neoplasms of the bile duct (IPNB). Diagnostic criteria, carcinogenesis and differential diagnostics].
    Schlitter AM; Klöppel G; Esposito I
    Pathologe; 2013 Nov; 34 Suppl 2():235-40. PubMed ID: 24196621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next-generation sequencing identifies distinct clinicopathologic and molecular entities of intraductal papillary neoplasms of the bile duct.
    Yang CY; Huang WJ; Tsai JH; Cheng A; Chen CC; Hsu HP; Jeng YM
    Mod Pathol; 2019 Nov; 32(11):1637-1645. PubMed ID: 31231124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoplastic Progression in Intraductal Papillary Neoplasm of the Bile Duct.
    Zen Y; Akita M
    Arch Pathol Lab Med; 2024 Sep; 148(9):989-996. PubMed ID: 36800543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic characterization of precursors and cholangiocarcinoma referring to peribiliary capillary plexus: a new pathologic approach to bile duct neoplasm.
    Nakanuma Y; Kakuda Y; Canh HN; Sasaki M; Harada K; Sugino T
    Virchows Arch; 2024 Aug; 485(2):257-268. PubMed ID: 39008118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Preoperative
    Ikeno Y; Seo S; Yamamoto G; Nakamoto Y; Uemoto Y; Fuji H; Yoshino K; Yoh T; Taura K; Uemoto S
    Anticancer Res; 2018 Jun; 38(6):3677-3682. PubMed ID: 29848727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis.
    Itatsu K; Zen Y; Ohira S; Ishikawa A; Sato Y; Harada K; Ikeda H; Sasaki M; Nimura Y; Nakanuma Y
    Liver Int; 2007 Nov; 27(9):1174-84. PubMed ID: 17919228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage.
    Nakanuma Y; Jang KT; Fukushima N; Furukawa T; Hong SM; Kim H; Lee KB; Zen Y; Jang JY; Kubota K
    J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):181-187. PubMed ID: 29272078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premalignant lesions of cholangiocarcinoma: characteristics on ultrasonography and MRI.
    Siripongsakun S; Sapthanakorn W; Mekraksakit P; Vichitpunt S; Chonyuen S; Seetasarn J; Bhumiwat S; Sricharunrat T; Srittanapong S
    Abdom Radiol (NY); 2019 Jun; 44(6):2133-2146. PubMed ID: 30820627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes.
    Aoki Y; Mizuma M; Hata T; Aoki T; Omori Y; Ono Y; Mizukami Y; Unno M; Furukawa T
    J Pathol; 2020 May; 251(1):38-48. PubMed ID: 32100878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal tubulopapillary neoplasms of the bile ducts: identity, clinicopathologic characteristics, and differential diagnosis of a distinct entity among intraductal tumors.
    Pehlivanoglu B; Adsay V
    Hum Pathol; 2023 Feb; 132():12-19. PubMed ID: 35934108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathways of genetic transformation in cholangiocarcinogenesis.
    Serafini FM; Radvinsky D
    Cancer Genet; 2016 Dec; 209(12):554-558. PubMed ID: 27720541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Tumor Location on Postoperative Outcome of Intraductal Papillary Neoplasm of the Bile Duct.
    Matsumoto T; Kubota K; Hachiya H; Sakuraoka Y; Shiraki T; Shimizu T; Mori S; Iso Y; Kato M; Yamagishi H; Imai Y; Aoki T
    World J Surg; 2019 May; 43(5):1313-1322. PubMed ID: 30659344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal Papillary Neoplasm of Bile Duct: Updated Clinicopathological Characteristics and Molecular and Genetic Alterations.
    Nakanuma Y; Uesaka K; Kakuda Y; Sugino T; Kubota K; Furukawa T; Fukumura Y; Isayama H; Terada T
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
    Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y
    Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological features of precancerous and early cancerous lesions of biliary tract carcinoma.
    Aishima S; Kubo Y; Tanaka Y; Oda Y
    J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):448-52. PubMed ID: 24446428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of epigenetic regulation in cholangiocarcinogenesis.
    Zhong B; Liao Q; Wang X; Wang X; Zhang J
    Biomed Pharmacother; 2023 Oct; 166():115290. PubMed ID: 37557012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.